Bloomage BioTechnology Corporation Limited (688363.SS)
CNY 47.93
(-0.15%)
CNY 47.93
(-0.15%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 8.47 Billion CNY | -2.44% |
| 2022 | 8.68 Billion CNY | 15.7% |
| 2021 | 7.5 Billion CNY | 31.26% |
| 2020 | 5.71 Billion CNY | 14.99% |
| 2019 | 4.97 Billion CNY | 140.06% |
| 2018 | 2.07 Billion CNY | 9.98% |
| 2017 | 1.88 Billion CNY | 11.81% |
| 2016 | 1.68 Billion CNY | -23.42% |
| 2015 | 2.19 Billion CNY | 127.79% |
| 2014 | 965.44 Million CNY | 25.66% |
| 2013 | 768.3 Million CNY | 62.0% |
| 2012 | 474.25 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 8.68 Billion CNY | 0.83% |
| 2024 Q1 | 8.31 Billion CNY | -1.83% |
| 2024 Q2 | 8.61 Billion CNY | 3.62% |
| 2023 Q3 | 8.34 Billion CNY | -0.22% |
| 2023 FY | 8.47 Billion CNY | -2.44% |
| 2023 Q2 | 8.36 Billion CNY | -1.08% |
| 2023 Q1 | 8.45 Billion CNY | -2.56% |
| 2023 Q4 | 8.47 Billion CNY | 1.44% |
| 2022 Q3 | 7.9 Billion CNY | 0.95% |
| 2022 Q2 | 7.83 Billion CNY | 5.63% |
| 2022 Q1 | 7.41 Billion CNY | -1.19% |
| 2022 FY | 8.68 Billion CNY | 15.7% |
| 2022 Q4 | 8.68 Billion CNY | 9.81% |
| 2021 Q1 | 6.05 Billion CNY | 5.86% |
| 2021 Q3 | 6.64 Billion CNY | 1.55% |
| 2021 Q4 | 7.5 Billion CNY | 12.84% |
| 2021 FY | 7.5 Billion CNY | 31.26% |
| 2021 Q2 | 6.54 Billion CNY | 8.2% |
| 2020 Q2 | 5.33 Billion CNY | 6.13% |
| 2020 FY | 5.71 Billion CNY | 14.99% |
| 2020 Q3 | 5.3 Billion CNY | -0.61% |
| 2020 Q1 | 5.03 Billion CNY | 1.21% |
| 2020 Q4 | 5.71 Billion CNY | 7.72% |
| 2019 FY | 4.97 Billion CNY | 140.06% |
| 2019 Q1 | 2.09 Billion CNY | 1.28% |
| 2019 Q2 | 2.34 Billion CNY | 12.03% |
| 2019 Q3 | 2.5 Billion CNY | 6.43% |
| 2019 Q4 | 4.97 Billion CNY | 98.8% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | 2.07 Billion CNY | 9.98% |
| 2018 Q4 | 2.07 Billion CNY | 0.0% |
| 2017 Q1 | 2.44 Billion CNY | 0.91% |
| 2017 Q2 | 2.44 Billion CNY | 0.0% |
| 2017 FY | 1.88 Billion CNY | 11.81% |
| 2016 Q2 | 2.17 Billion CNY | 0.0% |
| 2016 Q4 | 2.41 Billion CNY | 0.0% |
| 2016 Q3 | 2.41 Billion CNY | 11.11% |
| 2016 Q1 | 2.17 Billion CNY | -0.99% |
| 2016 FY | 1.68 Billion CNY | -23.42% |
| 2015 Q2 | 1.25 Billion CNY | 0.0% |
| 2015 Q3 | 2.19 Billion CNY | 75.12% |
| 2015 Q4 | 2.19 Billion CNY | 0.0% |
| 2015 Q1 | 1.25 Billion CNY | 30.08% |
| 2015 FY | 2.19 Billion CNY | 127.79% |
| 2014 FY | 965.44 Million CNY | 25.66% |
| 2014 Q3 | 965.44 Million CNY | 6.63% |
| 2014 Q1 | 905.45 Million CNY | 17.85% |
| 2014 Q2 | 905.45 Million CNY | 0.0% |
| 2014 Q4 | 965.44 Million CNY | 0.0% |
| 2013 FY | 768.3 Million CNY | 62.0% |
| 2013 Q2 | 667.7 Million CNY | 0.0% |
| 2013 Q1 | 667.7 Million CNY | 40.79% |
| 2013 Q4 | 768.3 Million CNY | 0.0% |
| 2013 Q3 | 768.3 Million CNY | 15.07% |
| 2012 FY | 474.25 Million CNY | 0.0% |
| 2012 Q4 | 474.25 Million CNY | 0.0% |
| 2012 Q3 | 474.25 Million CNY | 0.0% |